MDGL stock news
This page provides real-time market news, earnings updates, and company announcements related to Madrigal Pharmaceuticals, Inc. (MDGL).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-30 08:26 EST
Healthcare dealmakers head to San Francisco hoping for megamergers in 2026
101 finance2026-01-09 16:30:23
Kailera’s Ron Renaud discusses how a startup with connections to China can stand out in the obesity market
101 finance2026-01-20 12:09:29
Madrigal Pharmaceuticals, Inc. announced an exclusive global licensing agreement to introduce six preclinical-stage siRNA (small interfering RNA) programs, aiming to significantly expand its research and development pipeline for metabolic dysfunction-associated steatohepatitis (MASH).
老虎证券2026-02-11 10:07:01
What to Expect From These Drug/Biotech Players This Earnings Season?
Finviz2026-02-16 20:18:39
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-17 21:09:43
Facing AI Competition Threat, Pinterest Launches "Red Alert" Project
新浪财经2026-02-18 09:09:38
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:03:41
Madrigal: Q4 Financial Results Overview
101 finance2026-02-19 12:30:38
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Finviz2026-02-20 16:03:41
Madrigal's 1.13% Price Drop Amid 108% Volume Surge Pushes It to 463rd Most Active Stock
101 finance2026-02-26 00:57:54
Madrigal's MASH Dominance: Assessing the Scalability of a Near-Blockbuster
101 finance2026-03-03 07:45:36
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy
Finviz2026-03-10 12:03:11
This leading manufacturer of specialized heart monitors has recently attracted the attention of a prominent healthcare investment fund.
101 finance2026-03-20 19:57:40
This $116 Million Purchase Accompanies a 360% Surge in Shares and Appears to Show Strong Confidence in a Major Drug Debut
101 finance2026-03-21 23:39:16
This Recent $193 Million Investment Focuses on a Biotech Firm Generating $689 Million in Revenue With Promising Turnaround Potential
101 finance2026-03-21 23:48:10
Madrigal Ignites: A 5.5% Surge to $469.75 Ignites Biotech Futures Without a Whispered Catalyst
101 finance2026-03-25 16:57:38
ALT Pemvidutide Uncovered: How It Stands Apart in MASH
101 finance2026-03-26 14:27:56
Madrigal (MDGL) Spikes 12% — But Volume Says No
101 finance2026-03-26 19:42:51
Madrigal Surges 11.66%: A Volatile Breakout Defies Sector Stagnation as Bulls Test $572
101 finance2026-03-26 19:54:34
United Therapeutics (UTHR) Rises 5.7% Following Recent Earnings Release: Will the Momentum Persist?
101 finance2026-03-27 16:34:19
MDGL Soars 16% Despite Bearish Technicals and Neutral Analysts
101 finance2026-03-28 01:33:47
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Finviz2026-02-17 21:09:43
Facing AI Competition Threat, Pinterest Launches "Red Alert" Project
新浪财经2026-02-18 09:09:38
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
Finviz2026-02-19 12:03:41
Madrigal: Q4 Financial Results Overview
101 finance2026-02-19 12:30:38
Madrigal Q4 Earnings Miss, MASH Drug Sales Drive Top Line, Stock Down
Finviz2026-02-20 16:03:41
Madrigal's 1.13% Price Drop Amid 108% Volume Surge Pushes It to 463rd Most Active Stock
101 finance2026-02-26 00:57:54
Madrigal's MASH Dominance: Assessing the Scalability of a Near-Blockbuster
101 finance2026-03-03 07:45:36
What Makes Madrigal Pharma (MDGL) One of the Shorted Biotech Stocks to Buy
Finviz2026-03-10 12:03:11
This leading manufacturer of specialized heart monitors has recently attracted the attention of a prominent healthcare investment fund.
101 finance2026-03-20 19:57:40
This $116 Million Purchase Accompanies a 360% Surge in Shares and Appears to Show Strong Confidence in a Major Drug Debut
101 finance2026-03-21 23:39:16
This Recent $193 Million Investment Focuses on a Biotech Firm Generating $689 Million in Revenue With Promising Turnaround Potential
101 finance2026-03-21 23:48:10
Madrigal Ignites: A 5.5% Surge to $469.75 Ignites Biotech Futures Without a Whispered Catalyst
101 finance2026-03-25 16:57:38
ALT Pemvidutide Uncovered: How It Stands Apart in MASH
101 finance2026-03-26 14:27:56
Madrigal (MDGL) Spikes 12% — But Volume Says No
101 finance2026-03-26 19:42:51
Madrigal Surges 11.66%: A Volatile Breakout Defies Sector Stagnation as Bulls Test $572
101 finance2026-03-26 19:54:34
United Therapeutics (UTHR) Rises 5.7% Following Recent Earnings Release: Will the Momentum Persist?
101 finance2026-03-27 16:34:19
MDGL Soars 16% Despite Bearish Technicals and Neutral Analysts
101 finance2026-03-28 01:33:47
MDGL stock chart
MDGL stock detailsMDGL stock price change
On the last trading day, MDGL stock closed at 510.68 USD, with a price change of -1.56% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more